elexxion AG
elexxion AG develops, produces, and sells dental lasers for soft and hard tissue applications primarily in Germany. The company offers dental diode lasers under the elexxion pico, elexxion nano, and elexxion claros names; and elexxion pico lite, a soft laser therapy. It also provides SNORE3 therapy; and perio green, a therapy product for the photothermal therapy of periodontology and periimplanti… Read more
elexxion AG (E8X) - Net Assets
Latest net assets as of December 2022: €-0.01 EUR
Based on the latest financial reports, elexxion AG (E8X) has net assets worth €-0.01 EUR as of December 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€4.57K) and total liabilities (€4.57K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-0.01 |
| % of Total Assets | -0.0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 459.29 |
elexxion AG - Net Assets Trend (2004–2022)
This chart illustrates how elexxion AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for elexxion AG (2004–2022)
The table below shows the annual net assets of elexxion AG from 2004 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | €0.00 | -- |
| 2021-12-31 | €-2.94 Million | -13.90% |
| 2020-12-31 | €-2.58 Million | -36.30% |
| 2019-12-31 | €-1.89 Million | -- |
| 2018-12-31 | €0.00 | -- |
| 2017-12-31 | €0.00 | -- |
| 2016-12-31 | €0.00 | -- |
| 2015-12-31 | €0.00 | -- |
| 2014-12-31 | €-0.01 | -- |
| 2013-12-31 | €0.00 | -- |
| 2012-12-31 | €1.35K | -97.79% |
| 2011-12-31 | €60.94K | -92.01% |
| 2010-12-31 | €762.79K | +137.76% |
| 2009-12-31 | €320.82K | -86.93% |
| 2008-12-31 | €2.45 Million | -28.19% |
| 2007-12-31 | €3.42 Million | +24.44% |
| 2006-12-31 | €2.75 Million | +1407.76% |
| 2005-12-31 | €182.12K | -39.52% |
| 2004-12-31 | €301.14K | -- |
Equity Component Analysis
This analysis shows how different components contribute to elexxion AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2371854400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €9.90 Million | % |
| Other Comprehensive Income | €3.92 Million | % |
| Other Components | €6.32 Million | % |
| Total Equity | €-3.92 Million | 100.00% |
elexxion AG Competitors by Market Cap
The table below lists competitors of elexxion AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nordea Inv EU SmCap Stars KL1
CO:NDIESCSKL1
|
$199.19K |
|
Wealth Invest Optimal Stabil
CO:WEIOS
|
$199.21K |
|
Currys PLC
LSE:CURY
|
$199.22K |
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
$199.27K |
|
TOKYO TATEMONO CO
MU:T6R
|
$199.01K |
|
Lowell Farms Inc
OTCQB:LOWLF
|
$198.86K |
|
FERNHEIZWERK NEUK
BE:FHW
|
$198.79K |
|
Skychain Technologies Inc
PINK:SKTCF
|
$198.78K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in elexxion AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -2,937,658 to -3,920,728, a change of -983,070.
- Net loss of 983,069 reduced equity.
- Other comprehensive income increased equity by 983,070.
- Other factors decreased equity by 983,071.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-983.07K | -25.07% |
| Other Comprehensive Income | €983.07K | +25.07% |
| Other Changes | €-983.07K | -25.07% |
| Total Change | €- | % |
Book Value vs Market Value Analysis
This analysis compares elexxion AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | €0.07 | €0.14 | x |
| 2005-12-31 | €0.05 | €0.14 | x |
| 2006-12-31 | €0.68 | €0.14 | x |
| 2007-12-31 | €0.38 | €0.14 | x |
| 2008-12-31 | €0.27 | €0.14 | x |
| 2009-12-31 | €0.04 | €0.14 | x |
| 2010-12-31 | €0.13 | €0.14 | x |
| 2011-12-31 | €0.01 | €0.14 | x |
| 2012-12-31 | €0.00 | €0.14 | x |
| 2013-12-31 | €-0.05 | €0.14 | x |
| 2014-12-31 | €-0.54 | €0.14 | x |
| 2015-12-31 | €-0.54 | €0.14 | x |
| 2016-12-31 | €-0.60 | €0.14 | x |
| 2017-12-31 | €-0.70 | €0.14 | x |
| 2018-12-31 | €-0.70 | €0.14 | x |
| 2019-12-31 | €-0.19 | €0.14 | x |
| 2020-12-31 | €-0.26 | €0.14 | x |
| 2021-12-31 | €-0.30 | €0.14 | x |
| 2022-12-31 | €-0.40 | €0.14 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently elexxion AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -221.47%
- • Asset Turnover: 0.10x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-6547.36%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 23.31% | 4.09% | 2.66x | 2.14x | €40.09K |
| 2005 | -204.07% | -19.43% | 2.17x | 4.85x | €-389.85K |
| 2006 | -48.16% | -55.61% | 0.59x | 1.47x | €-1.60 Million |
| 2007 | -50.08% | -62.67% | 0.59x | 1.36x | €-2.05 Million |
| 2008 | -118.02% | -103.34% | 0.63x | 1.82x | €-3.14 Million |
| 2009 | -664.84% | -90.91% | 0.77x | 9.50x | €-2.17 Million |
| 2010 | -178.26% | -88.36% | 1.37x | 1.47x | €-1.44 Million |
| 2011 | -2137.40% | -48.32% | 1.90x | 23.25x | €-1.31 Million |
| 2012 | -121022.36% | -79.25% | 1.46x | 1048.76x | €-1.63 Million |
| 2013 | 0.00% | -54.14% | 1.24x | 0.00x | €-1.19 Million |
| 2014 | 0.00% | -41.77% | 0.68x | 0.00x | €-250.27 |
| 2015 | 0.00% | -36.49% | 0.58x | 0.00x | €-177.18 |
| 2016 | 0.00% | 48.91% | 0.78x | 0.00x | €1.30K |
| 2017 | 0.00% | -86.30% | 0.69x | 0.00x | €-549.56 |
| 2018 | 0.00% | -139.10% | 0.24x | 0.00x | €-268.95 |
| 2019 | 0.00% | -158.92% | 0.77x | 0.00x | €-890.54K |
| 2020 | 0.00% | -93.80% | 0.84x | 0.00x | €-429.05K |
| 2021 | 0.00% | -34.84% | 1.21x | 0.00x | €-64.65K |
| 2022 | 0.00% | -221.47% | 0.10x | 0.00x | €-591.00K |
Industry Comparison
This section compares elexxion AG's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $281,140,437
- Average return on equity (ROE) among peers: -82.83%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| elexxion AG (E8X) | €-0.01 | 23.31% | N/A | $199.10K |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |